Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/14/2003CN1418112A Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
05/14/2003CN1418108A Parenteral use of bacterial phage associated lysing enzymes for therapeutic treatment of bacterial infections
05/14/2003CN1418098A Tamper-resistant oral opioid agonist formulations
05/14/2003CN1418097A Oxazolidinone toble formulation
05/14/2003CN1418092A Stabilised oversaturated transdermal therapeutical matrix system
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1418090A Process for preparation of accelerated release formulations using compressed fluids
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1418062A Digestable chewing gum
05/14/2003CN1417326A Latent-energy regeneration cell
05/14/2003CN1417242A Polyglycol grafted and modified cyanoacrylate copolymer and its prepn
05/14/2003CN1416902A Combined polymer-medicine micelle and its prepn process
05/14/2003CN1416885A Andrographis gel as supplementary medicine for treating preiodontitis
05/14/2003CN1416812A Liver-targeting mitomycin magnetic nano particle and its prepn and application in medicine
05/14/2003CN1416808A Oral biological macromolecular medicine administrating system based on biological adhesive microballoon
05/14/2003CN1108170C Buffering liquid for staphylococcus Aureus Injection and stephylococcus Aureus Injection with buffering liquid
05/14/2003CN1108155C Preparation absorbed through skin, containing woluke kinds of medicine
05/14/2003CN1108153C Oral compositions containing ondansetron
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562928 What is described herein is a terpolymer of maleic acid (MAA)/ maleic anhydride (MAN)/alkylvinylether (AVE), made by partial cyclization, e.g. 1-99%, of a maleic acid/alkylvinylether copolymer, preferably comprising, in mole
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562872 Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562826 To maintain human ranolazine plasma levels at therapeutic levels
05/13/2003US6562802 Anionic ethylene amine scavenger; and cationic, hydrophilic amine containing polymer like chitosan and derivatives, cationic polyethylenes, DEAE-4, and polyornithine
05/13/2003US6562798 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562781 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/13/2003US6562778 Solubilizers containing alk(en)yl oligoglycosides and polyol components, and methods of solubilizing using the same
05/13/2003US6562606 Methods and compositions for disrupting the epithelial barrier function
05/13/2003US6562392 Hard caramel product
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562372 Tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
05/13/2003US6562370 A combination of an estrogen and progestin for female hormoe replacement therapy, to provide contraception; minimizes skin damage, irritation or sensitization
05/13/2003US6562369 Administering drug to localized region of human patient's body surface in combination with hydroxide releasing agent applied to body surface
05/13/2003US6562368 Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
05/13/2003US6562367 Solvent free formulation; minimum thermal exposure; high bioavailability; sustained release
05/13/2003US6562363 Bioadhesive compositions and methods for topical administration of active agents
05/13/2003US6562362 Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction
05/13/2003US6562358 Nontoxic vernix compositions and method of producing
05/13/2003US6562356 Oil in water emulsions
05/13/2003US6562350 Combined vaccine against both HAV and measles virus and method of producing it
05/13/2003US6562329 Administering lipase inhibitors
05/13/2003US6562318 Nerve adhesion molecule coupled to active substance; undergoes axonal transport following neuronal endocytosis when contacted with nerve terminus in vascularized innervated tissue
05/13/2003US6562317 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content
05/13/2003US6562316 Drug delivery system with two-step targeting
05/13/2003CA2315877C Facilitated oxygen delivery in conjunction with hemodilution
05/13/2003CA2235607C Process for aqueous granulation of clarithromycin
05/13/2003CA2138975C Topical application composition
05/08/2003WO2003038103A1 Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
05/08/2003WO2003038054A2 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds
05/08/2003WO2003037607A1 A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037385A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037383A1 An antineoplastic- dendritic polymer drug delivery system
05/08/2003WO2003037382A1 Low concentration of peroxide for treating or preventing vaginal infections
05/08/2003WO2003037381A1 Vaginally administerd anti-dysrhythmic agents for treating pelvic pain and infertility
05/08/2003WO2003037380A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/08/2003WO2003037379A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003WO2003037375A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003WO2003037374A1 Method of treatment of vulval vestibulitis
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037337A1 Depot formulations of iloperidone and a star polymer
05/08/2003WO2003037314A2 Medical compositions for intravesical treatment of bladder cancer
05/08/2003WO2003037312A2 Ribavirin syrup formulations
05/08/2003WO2003037307A1 Volatilization of a drug from an inclusion complex
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037298A2 Bowel cleansing agent
05/08/2003WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037291A1 Cream for treatment of skin injured by the sun
05/08/2003WO2003037286A1 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis
05/08/2003WO2003037278A1 Surfactant-containing cosmetic cleaning emulsions
05/08/2003WO2003037272A2 Thymosin alpha 1 peptide/polymer conjugates
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037244A2 System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
05/08/2003WO2003037220A1 Improved endoprosthetic device
05/08/2003WO2003037159A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
05/08/2003WO2003022192B1 Eustachian tube stent
05/08/2003WO2003011224A3 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/08/2003WO2003004000A3 Topical composition for treating pain
05/08/2003WO2002102305B1 Adjuvant composition for mucosal and injection delivered vaccines
05/08/2003WO2002102304A3 Gum resin as a carrier for topical application of pharmacologically active agents
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002097114A3 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
05/08/2003WO2002087494A3 Novel vaccine
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002085283A3 Vaccine against tuberculosis
05/08/2003WO2002083076A3 Method for inhibiting atherosclerotic plaque formation
05/08/2003WO2002053089B1 Stable skin conditioning compositions containing retinoid boosters
05/08/2003WO2002036110A3 Oral self-emulsifying formulations of pyranone protease inhibitors
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/08/2003WO2001082899A9 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
05/08/2003US20030088236 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
05/08/2003US20030088233 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
1 ... 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 ... 1712